The Risk of Cardiac Events and Genotype-Based Management of LQTS Patients

被引：17

作者：

Markiewicz-Loskot, Grazyna ^{[3
,4
]}

Moric-Janiszewska, Ewa ^{[1
]}

Mazurek, Urszula ^{[2
]}

机构：

[1] Med Univ Silesia, Dept Biochem, PL-41200 Sosnowiec, Poland

[2] Med Univ Silesia, Dept Mol Biol, PL-41200 Sosnowiec, Poland

[3] Med Univ Silesia, Dept Pediat Cardiol, Katowice, Poland

[4] Med Univ Silesia, Dept Nursing & Social Med Problems, Katowice, Poland

来源：

ANNALS OF NONINVASIVE ELECTROCARDIOLOGY | 2009年 / 14卷 / 01期

关键词：

congenital long QT syndrome; ion channel; genotype-phenotype correlation; arrhythmias; beta-blocker therapy; LONG-QT-SYNDROME; BIDIRECTIONAL VENTRICULAR-TACHYCARDIA; BETA-ADRENERGIC AGONISTS; CLINICAL-COURSE; SYMPATHETIC DENERVATION; PERICARDIAL DISEASES; EXERCISE PHYSIOLOGY; CHANNEL DYSFUNCTION; SPATIAL-DISPERSION; ARRHYTHMIC EVENTS;

D O I：

10.1111/j.1542-474X.2008.00278.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

This review discusses the risk of cardiac events and genotype-based management of LQTS. We describe here the genetic background of long QT syndrome and the eleven different genes for ion-channels and a structural anchoring protein associated with that disorder. Clinical Background section discusses the risk of cardiac events associated with different LQTS types. Management and Prevention section describes in turn gene-specific therapy, which was based on the identification of the gene defect and the dysfunction of the associated transmembrane ion channel. In patients affected by LQTS, genetic analysis is useful for risk stratification and for making therapeutic decisions. A recent study reported a quite novel pathogenic mechanism for LQTS and suggested that treatments aimed at scaffolding proteins rather than specific ion channels may be an alternative to antiarrhythmic strategy in the future. Ann Noninvasive Electrocardiol 2009;14(1):86-92.

引用

页码：86 / 92

页数：7

共 84 条

[11] Genetically defined therapy of inherited long-QT syndrome - Correction of abnormal repolarization by potassium [J].

Compton, SJ ;

Lux, RL ;

Ramsey, MR ;

Strelich, KR ;

Sanguinetti, MC ;

Green, LS ;

Keating, MT ;

Mason, JW .

CIRCULATION, 1996, 94 (05) :1018-1022

[12] Gender differences in the long QT syndrome:: effects of β-adrenoceptor blockade [J].

Conrath, CE ;

Wilde, AAM ;

Jongbloed, RJE ;

Alders, M ;

van Langen, IM ;

van Tintelen, JP ;

Doevendans, PA ;

Opthof, T .

CARDIOVASCULAR RESEARCH, 2002, 53 (03) :770-776

[13] Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol - Consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology [J].

Corrado, D ;

Pelliccia, A ;

Bjornstad, HH ;

Vanhees, L ;

Biffi, A ;

Borjesson, M ;

Panhuyzen-Goedkoop, N ;

Deligiannis, A ;

Solberg, E ;

Dugmore, D ;

Mellwig, KP ;

Assanelli, D ;

Delise, P ;

van-Buuren, F ;

Anastasakis, A ;

Heidbuchel, H ;

Hoffmann, E ;

Fagard, R ;

Priori, SG ;

Basso, C ;

Arbustini, E ;

Blomstrom-Lundqvist, C ;

McKenna, WJ ;

Thiene, G .

EUROPEAN HEART JOURNAL, 2005, 26 (05) :516-524

[14] Long-term follow-up of patients with long-QT syndrome treated with β-blockers and continuous pacing [J].

Dorostkar, PC ;

Eldar, M ;

Belhassen, B ;

Scheinman, MM .

CIRCULATION, 1999, 100 (24) :2431-2436

[15] COMBINED USE OF BETA-ADRENERGIC BLOCKING-AGENTS AND LONG-TERM CARDIAC PACING FOR PATIENTS WITH THE LONG QT SYNDROME [J].

ELDAR, M ;

GRIFFIN, JC ;

VANHARE, GF ;

WITHERELL, C ;

BHANDARI, A ;

BENDITT, D ;

SCHEINMAN, MM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1992, 20 (04) :830-837

[16] Cyclosporin and Timothy syndrome increase mode 2 gating of CaV1.2 calcium channels through aberrant phosphorylation of S6 helices [J].

Erxleben, C ;

Liao, YH ;

Gentile, S ;

Chin, D ;

Gomez-Alegria, C ;

Mori, Y ;

Birnbaumer, L ;

Armstrong, DL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (10) :3932-3937

[17] A new oral therapy for long QT syndrome -: Long-term oral potassium improves repolarization in patients with HERG mutations [J].

Etheridge, SP ;

Compton, SJ ;

Tristani-Firouzi, M ;

Mason, JW .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (10) :1777-1782

[18] Long QT syndrome in children in the era of implantable defibrillators [J].

Etheridge, Susan P. ;

Sanatani, Shubhayan ;

Cohen, Mitchell I. ;

Albaro, Cecilia A. ;

Saarel, Elizabeth V. ;

Bradley, David J. .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2007, 50 (14) :1335-1340

[19] Risk factors for aborted cardiac arrest and sudden cardiac death in children with the congenital long-QT syndrome [J].

Goldenberg, Ilan ;

Moss, Arthur J. ;

Peterson, Derick R. ;

McNitt, Scott ;

Zareba, Wojciech ;

Andrews, Mark L. ;

Robinson, Jennifer L. ;

Locati, Emanuela H. ;

Ackerman, Michael J. ;

Benhorin, Jesaia ;

Kaufman, Elizabeth S. ;

Napolitano, Carlo ;

Priori, Silvia G. ;

Qi, Ming ;

Schwartz, Peter J. ;

Towbin, Jeffrey A. ;

Vincent, Michael ;

Zhang, Li .

CIRCULATION, 2008, 117 (17) :2184-2191

[20] Long-QT syndrome after age 40 [J].